Tosoh Bioscience Sustainability Profile
Tosoh Bioscience, a leading name in the biotechnology sector, is headquartered in Great Britain and operates extensively across Europe, Asia, and North America. Founded in 2003, the company has established itself as a key player in the development and manufacturing of high-quality chromatography products and bioprocessing solutions. With a focus on innovative technologies, Tosoh Bioscience offers a diverse range of core products, including affinity chromatography resins and analytical instruments, which are renowned for their reliability and performance. The company’s commitment to quality and customer satisfaction has solidified its market position, making it a trusted partner for laboratories and biopharmaceutical manufacturers worldwide. Notable achievements include significant advancements in protein purification and a robust portfolio that supports the evolving needs of the life sciences industry.
DitchCarbon Score
How does Tosoh Bioscience's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Tosoh Bioscience's score of 58 is higher than 76% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Tosoh Bioscience's reported carbon emissions
In 2024, Tosoh Bioscience reported significant carbon emissions, totalling approximately 7,333,000,000 kg CO2e for Scope 1, 468,000,000 kg CO2e for Scope 2, and 5,834,000,000 kg CO2e for Scope 3. This reflects a slight decrease in Scope 1 emissions from 2023, where they were about 7,645,000,000 kg CO2e, while Scope 2 emissions remained relatively stable. The total emissions for 2023 were approximately 8,112,000,000 kg CO2e for Scope 1 and 2 combined. Tosoh Bioscience has set ambitious long-term targets to reduce its greenhouse gas emissions. The company aims to achieve a 30% reduction in Scope 1 and 2 emissions by fiscal 2031 compared to fiscal 2019 levels. This commitment underscores their dedication to addressing climate change and improving sustainability within their operations. The emissions data is not cascaded from any parent organization, indicating that these figures are independently reported by Tosoh Bioscience Limited. The company continues to monitor and report its emissions transparently, aligning with industry standards for climate accountability.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|
| Scope 1 | 7,797,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 |
| Scope 2 | 535,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | 6,014,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 |
How Carbon Intensive is Tosoh Bioscience's Industry?
How Carbon Intensive is Tosoh Bioscience's Location?
Tosoh Bioscience's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Tosoh Bioscience has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
